Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab-Reference-Cited by-同舟云学术

Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab

Published:2014-11-14 Issue:1 Volume:14 Page:
ISSN:1470-7330
Container-title:Cancer Imaging
language:en
Short-container-title:cancer imaging

Author:

Leu Kevin,Enzmann Dieter R,Woodworth Davis C,Harris Robert J,Tran Anh N,Lai Albert,Nghiemphu Phioanh L,Pope Whitney B,Cloughesy Timothy F,Ellingson Benjamin M

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/s40644-014-0031-z.pdf

Reference19 articles.

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 2012, 14(5):v1-v49. 10.1093/neuonc/nos218

2. Johnson DR, O’Neill BP: Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 2012, 107: 359–364. 10.1007/s11060-011-0749-4

3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352: 987–996. 10.1056/NEJMoa043330

4. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284: 1994–1998. 10.1126/science.284.5422.1994

5. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994, 367: 576–579. 10.1038/367576a0

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative diagnosis of carotid blowout syndrome with CT perfusion;European Journal of Radiology;2024-11

2. Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis;American Journal of Neuroradiology;2022-01-20

3. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults;Journal of Neuro-Oncology;2021-10-25

4. Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging;EJNMMI Research;2021-08-16

5. Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial;Neuro-Oncology;2020-07-17